Biotics AI, Battlefield 2023, gains FDA approval for its AI-powered fetal ultrasound product
TechCrunch Disrupt Battlefield 2023 winner, Biotics AI, announced on Monday that it has received FDA clearance for its AI software …
Real-time market intelligence across asset classes
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
Over the last 30 days, AI sentiment for TECH skewed neutral (216 of 490 scored calls).
AI-curated news influencing TECH price, sentiment, and trend
TechCrunch Disrupt Battlefield 2023 winner, Biotics AI, announced on Monday that it has received FDA clearance for its AI software …
Welcome back to TechCrunch Mobility, your hub for all things “future of transportation.”
The U.S. stock market has pushed higher this year despite angst over the Federal Reserve’s independence and heightened tensions around …
The Magnificent Seven stocks now represent 35% to 40% of the S&P 500, creating historically high concentration risk. SPDR S&P …
A meltdown in software stocks has left several high-growth names trading at bargain prices, according to some on Wall Street.
Research Affiliates Founder and chairman of the board Rob Arnott sits down with Market Catalysts Anchor Julie Hyman to have …
Multi-Provider AI Analysis